Drreddys Laboratories | RDY - Gross Profit On Sales


Drreddys Laboratories reported INR46.81B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 111.79M 1.68M Sep/2025
Aurora Cannabis CAD 32.29M 4.34M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Canopy Growth CAD 21.9M 3.86M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Corcept Therapeutics USD 203.04M 12.04M Sep/2025
Drreddys Laboratories INR 46.81B 10.24B Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Novartis USD 10.82B 695M Sep/2025
Pacira USD 130.92M 5M Sep/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Richter Gedeon HUF 143.37B 4.3B Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Supernus Pharmaceuticals USD 148.81M 21.01M Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025